Your browser doesn't support javascript.
Disputes over the production and dissemination of misinformation in the time of COVID-19.
Cazzola, Mario; de Novellis, Vito; Bianco, Andrea; Rogliani, Paola; Matera, Maria Gabriella.
  • Cazzola M; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy. Electronic address: mario.cazzola@uniroma2.it.
  • de Novellis V; Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Bianco A; Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli"/Monaldi Hospital, Naples, Italy.
  • Rogliani P; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Matera MG; Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Respir Med ; 182: 106380, 2021 06.
Article in English | MEDLINE | ID: covidwho-1157712
ABSTRACT
Ultimate coronavirus disease 2019 (COVID-19) mitigation and crisis resolution is dependent on trustworthy data and actionable information. At present time, there is still no cure for COVID-19, although some treatments are being used in severe illness. Regrettably, as the SARS-CoV-2 virus spreads, the lack of cure has been accompanied by an increasing amount of medical misinformation. In particular, there is a lot of misinformation about how to treat patients who have tested positive for SARS-CoV-2 and who are asymptomatic or have mild symptoms and for whom management at home is deemed appropriate. In this editorial, we highlight the risks deriving from this misinformation, which often arises from the publication of studies that are not conceptually and methodologically accurate.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Prognostic study Limits: Humans Language: English Journal: Respir Med Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Prognostic study Limits: Humans Language: English Journal: Respir Med Year: 2021 Document Type: Article